Merck Commits Over €300 Million to Establish Cutting-Edge Life Science Production Hub in South Korea

  Matthias Heinzel, Member of the Executive Board of Merck and CEO Life Science, emphasized the strategic importance of this move, stating, "The Asia...

March 21, 2024 | Thursday | News
Samsung Ventures Backs BrickBio to Pave the Way for Next-Generation Therapies

Samsung Ventures, a key player in the life sciences sector, has made a strategic investment in BrickBio, Inc., a preclinical-stage biopharmaceutical compan...

March 19, 2024 | Tuesday | News
Korea University Study Explores a Novel and Precise Mitochondrial Gene Editing Method

          Targeted base editing of mammalian mtDNA is a powerful technology f...

February 26, 2024 | Monday | News
Rznomics Secures FDA Orphan Drug Designation for RZ-001 in Hepatocellular Carcinoma

The ODD granted to RZ-001 in HCC may allow it to receive 7 years of marketing exclusivity upon product approval, exemption from user fee and tax credits. T...

February 02, 2024 | Friday | News
Travere Licenses Sparsentan to Renalys Pharma for Japan, South Korea, Taiwan, and Southeast Asia

Travere Therapeutics, Inc. announced that it has entered into an exclusive licensing agreement with Renalys Pharma, Inc., to bring sparsentan, a dual endot...

January 26, 2024 | Friday | News
Seegene Teams Up with Microsoft for a Disease-Free World Vision

Strategic collaboration to open a new chapter in the field of molecular diagnostics that aspires to 'a world free from all diseases and future pandemics'...

January 24, 2024 | Wednesday | News
Parse Biosciences Secures $50M for Global Growth

Parse Biosciences, a leading provider of easily accessible and scalable solutions for single-cell sequencing, announced today that the company has raised $...

December 18, 2023 | Monday | News
South Korean Genomics Giant, Macrogen, Secures Strong Presence in Basel, Switzerland

  Macrogen Europe is seeking to expand within Switzerland from its foothold in Basel with its Sanger sequencing laborato...

December 13, 2023 | Wednesday | News
Successful Development and Manufacturing of Complex Biologics with Integrated CMC Solutions

The complexity of new biologics means that these life-changing therapeutics require complicated development and manufacturing processes. Product-specific c...

December 07, 2023 | Thursday | Opinion
Samsung Biologics engages suppliers to advance global decarbonization targets

The company invited supplier companies and external ESG specialists to discuss ESG-related requirements and recommendations as well as share successful cas...

November 28, 2023 | Tuesday | News
Seegene Boosts ESG Rating by Korea Institute of Corporate Governance and Sustainability

Seegene Inc. (KQ096530), a leading South Korean company providing a total solution for PCR molecular diagnostics, announced on November 10 that it has rece...

November 24, 2023 | Friday | News
AI-Powered Immune Phenotyping by Lunit SCOPE IO Marks First TKI-Resistant Lung Cancer Immunotherapy Success

Lunit SCOPE IO pivotal in first phase III trial successfully showing the efficacy of immunotherapy + chemotherapy for NSCLC patients with EGFR or ALK mut...

October 25, 2023 | Wednesday | News
SK pharmteco to showcase its extensive APIs and CGT capabilities in CPHI 2023

  With a dedicated booth in the main exhibition hall, SK pharmteco solidifies its global position as the most trusted CDMO partner in the pharmaceu...

October 20, 2023 | Friday | News
Samsung Bioepis Presents Phase 1 and 3 Clinical Results for SB16 Biosimilar to Prolia at ASBMR 2023

Phase 1 study for SB16, proposed biosimilar to Prolia, demonstrates pharmacokinetic (PK) bioequivalence between SB16, EU-sourced denosumab, and US-source...

October 16, 2023 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close